We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+8.99%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$21.9B
AUM Growth
+$21.9B
Cap. Flow
-$417M
Cap. Flow %
-1.9%
Top 10 Hldgs %
13.08%
Holding
3,337
New
135
Increased
1,103
Reduced
1,007
Closed
163

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$89.3M
2
KEYS icon
Keysight
KEYS
+$86M
3
NKE icon
Nike
NKE
+$78.3M
4
APH icon
Amphenol
APH
+$76.5M
5
CMCSA icon
Comcast
CMCSA
+$72.3M

Top Sells

Rank Stock Value
1
CE icon
Celanese
CE
+$108M
2
MNST icon
Monster Beverage
MNST
+$97.8M
3
SBUX icon
Starbucks
SBUX
+$79.7M
4
TXN icon
Texas Instruments
TXN
+$67.3M
5
CNC icon
Centene
CNC
+$64.3M

Sector Composition

Rank Sector Weight
1 Technology 18.83%
2 Financials 13.42%
3 Healthcare 13.25%
4 Industrials 9.77%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
L icon
1226
Loews
L
$24.6B
$93K ﹤0.01%
1,778
+147
+9% +$7.42K
PUK icon
1227
Prudential
PUK
$36.1B
$93K ﹤0.01%
2,529
-558
-18% -$19.7K
SKM icon
1228
SK Telecom
SKM
$11.8B
$93K ﹤0.01%
2,452
+996
+68% +$37.3K
UA icon
1229
Under Armour Class C
UA
$2.97B
$93K ﹤0.01%
4,950
+3,546
+253% +$62.4K
W icon
1230
Wayfair
W
$12.5B
$93K ﹤0.01%
1,033
BHC icon
1231
Bausch Health
BHC
$1.69B
$92K ﹤0.01%
3,109
LBRDA icon
1232
Liberty Broadband Class A
LBRDA
$4.72B
$92K ﹤0.01%
745
MELI icon
1233
Mercado Libre
MELI
$94.4B
$92K ﹤0.01%
161
-80
-33% -$44.3K
CS
1234
DELISTED
Credit Suisse Group
CS
$92K ﹤0.01%
6,910
+47
+0.7% +$601
IYJ icon
1235
iShares US Industrials ETF
IYJ
$2B
$91K ﹤0.01%
1,100
AAL icon
1236
American Airlines Group
AAL
$10.2B
$90K ﹤0.01%
3,157
-765
-20% -$21.8K
ALLE icon
1237
Allegion
ALLE
$13.7B
$90K ﹤0.01%
745
QGEN icon
1238
Qiagen
QGEN
$8.72B
$90K ﹤0.01%
2,530
-10,280
-80% -$382K
SEM
1239
DELISTED
Select Medical
SEM
$90K ﹤0.01%
7,250
+685
+10% +$7.38K
HDS
1240
DELISTED
HD Supply Holdings, Inc.
HDS
$90K ﹤0.01%
2,244
-206
-8% -$8.19K
AU icon
1241
AngloGold Ashanti
AU
$39.9B
$89K ﹤0.01%
4,027
-171
-4% -$3.44K
SCHG icon
1242
Schwab US Large-Cap Growth ETF
SCHG
$59.1B
$89K ﹤0.01%
7,744
+2,376
+44% +$26.2K
CVET
1243
DELISTED
Covetrus, Inc. Common Stock
CVET
$89K ﹤0.01%
6,748
+268
+4% +$3.25K
ITB icon
1244
iShares US Home Construction ETF
ITB
$2.41B
$88K ﹤0.01%
2,000
ACGL icon
1245
Arch Capital
ACGL
$37.2B
$87K ﹤0.01%
2,041
+100
+5% +$4.15K
CCU icon
1246
Compañía de Cervecerías Unidas
CCU
$2.2B
$87K ﹤0.01%
4,600
+3,688
+404% +$73.2K
KRE icon
1247
State Street SPDR S&P Regional Banking ETF
KRE
$4.55B
$87K ﹤0.01%
1,500
-425
-22% -$23.6K
SCHB icon
1248
Schwab US Broad Market ETF
SCHB
$42.9B
$87K ﹤0.01%
6,798
-5,700
-46% -$69.9K
ACM icon
1249
Aecom
ACM
$9.57B
$86K ﹤0.01%
2,007
+31
+2% +$1.28K
B
1250
Barrick Mining
B
$61.5B
$86K ﹤0.01%
4,629
-740
-14% -$12.7K

Similar funds

Glenmede Trust's Q4 2019 Portfolio in Review

As of Q4 2019, Glenmede Trust held 3,337 positions worth $21.9B, up 100,205% from $21.9M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Glenmede Trust's Q4 2019 filing shows 135 new, 1,103 increased, 1,007 reduced and 163 closed positions. Its largest new stake was Callon Petroleum Company: 285,674 shares worth $13.8M. The largest sale was Celanese, an estimated $108M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Glenmede Trust's largest Q4 2019 buy was Callon Petroleum Company: 285,674 shares worth $13.8M.
  • Glenmede Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $89.3M increase.
  • Glenmede Trust's biggest Q4 2019 reduction was Celanese, cutting an estimated $108M.
  • Glenmede Trust fully exited Celgene Corp in Q4 2019, selling an estimated $122K.
  • Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q4 2019.
  • Glenmede Trust opened 135 new positions and closed 163 in Q4 2019.
  • Glenmede Trust's portfolio value rose 100,205% quarter-over-quarter to $21.9B.

Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.